Skip to content
Screener

Neuropace, Inc. NPCE Other Non-Current Assets

Other Non-Current Assets at other companies

Medtronic logo
MedtronicMDT
$4.15B+15.7%
LivaNova logo
LivaNovaLIVN
$18.31M+27.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$1.65M+1,012%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$17.25M+42.0%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.06M+2.2%
CVRx, Inc. logo
CVRx, Inc.CVRX
$26K0.0%

Other financials

Income statement

See full
Revenue$22.8M+17.1%
Gross profit$18.9M+16.6%
Operating income-$5.1M+37.2%
Net income-$6.2M+28.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$12.8M-44.4%
Total debt$69.9M-2.2%
Total equity$11.9M-38.9%
Total assets$97.0M-8.6%

Cash flow

See full
Operating cash flow-$3.9M-87.1%
CapEx$125.0K-25.6%
Free cash flow-$4.0M-78.7%

Valuation

See full
Market cap$507.31M+74.0%
Enterprise value$564.47M+66.0%
P/S5.1×+1.7×

Profitability

See full
Gross margin79.6%+2.6pp
Operating margin-15.3%-4.3pp
Net margin-19.3%-5.2pp
FCF margin-12.2%-3.3pp

Returns & leverage

See full
Return on equity-122.1%-28.9pp
Debt / equity5.9×+2.2×
Current ratio4.9×-0.5×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:33 PM EDT
Fiscal quarter
Q4 FY2030
Calendar quarter
Q4 2030
Accession
0001528287-26-000030
(in thousands, except for share and per share amounts)June 30, 2026December 31, 2025
Property and equipment, net1,2431,125
Operating lease right-of-use asset9,21610,132
Restricted cash241122
Other assets98113
Total assets$96,991$105,565
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$4,204$1,776

Item 1. Financial Statements (Unaudited)

FAQ

What is Neuropace, Inc.'s other non-current assets?
Neuropace, Inc. (NPCE) reported other non-current assets of $98K in Q2 2026.
How has Neuropace, Inc.'s other non-current assets changed year-over-year?
Neuropace, Inc.'s other non-current assets increased by 12.6% year-over-year, from $87K to $98K.
What is the long-term trend for Neuropace, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Neuropace, Inc.'s other non-current assets has grown at a 37.5% compound annual growth rate (CAGR), from $23K to $113K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Neuropace, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude